Data Analytics in Cardiovascular Disease Prevention Programmes: A Critical Review of Predictive Accuracy, Implementation and Population Impact

Chidi Okafor *

Central Michigan University, Michigan, United States.

*Author to whom correspondence should be addressed.


Abstract

Cardiovascular disease remains the leading cause of death worldwide, and prevention programmes increasingly depend on data analytics to decide whom to screen, whom to treat and how to monitor progress. Electronic health records, linked administrative data, biobanks, wearable sensors, imaging archives and genomic information now support risk equations, machine-learning models, automated case-finding, clinical decision support and remote management. Existing reviews have concentrated largely on the discrimination of individual algorithms, leaving unresolved whether analytical gains translate into better prevention outcomes, for whom and at what cost. This critical narrative review examined literature published from January 2010 onwards, identified through several bibliographic databases, scholarly indexes, institutional sources and citation searching, and appraised it qualitatively according to study design, risk of bias, calibration and external validation, relevance to programme decisions and representativeness. The synthesis indicates that predictive accuracy is no longer the main constraint. Flexible machine-learning models generally add small increments in discrimination over well-specified regression equations, whereas miscalibration, transportability across populations and instability of individual predictions remain recurrent problems. Randomised evidence shows that analytics reliably changes processes of care, including risk documentation, case detection, statin prescribing and blood pressure control, but rarely demonstrates reductions in cardiovascular events. Screening trials for atrial fibrillation and general health checks illustrate that detection gains do not guarantee net clinical benefit. Registry-driven population health management combined with team-based treatment protocols provides the most consistent evidence of improved risk-factor control. Algorithmic bias arising from unrepresentative training data, inappropriate proxy outcomes and differential calibration across ethnic, socioeconomic and age groups threatens equity, particularly where data from low- and middle-income countries are scarce. Prescriptive approaches that target expected treatment benefit and causal analyses of routinely collected data are conceptually attractive but remain weakly validated. Future work should prioritise pragmatic trials with hard outcomes, routine calibration monitoring, equity auditing, implementation and economic evaluation, and analytics designed around actionable decisions rather than predictive performance alone. Data analytics can strengthen cardiovascular prevention, but only when embedded within accountable care pathways that convert risk information into effective and fair treatment.

Keywords: Cardiovascular risk prediction, machine learning, population health management, clinical decision support, atrial fibrillation screening, algorithmic fairness, implementation science, digital health


How to Cite

Okafor, Chidi. 2026. “Data Analytics in Cardiovascular Disease Prevention Programmes: A Critical Review of Predictive Accuracy, Implementation and Population Impact”. Asian Journal of Current Research 11 (4):421-52. https://doi.org/10.56557/ajocr/2026/v11i411412.

Downloads

Download data is not yet available.